# EDGAR Filing Document

**Accession Number:** 0001967969
**File Stem:** 0001062993-23-005875
**Filing Date:** 2023-3
**Character Count:** 10924
**Document Hash:** 3edfc00dc4c9ba14e82a6700326f5154
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-23-005875.hdr.sgml**: 20230303

**ACCESSION NUMBER**: 0001062993-23-005875

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230301

**FILED AS OF DATE**: 20230303

**DATE AS OF CHANGE**: 20230303

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Loh Sally
- **CENTRAL INDEX KEY:** 0001967969

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39221
- **FILM NUMBER:** 23704452

**MAIL ADDRESS:**
- **STREET 1:** 1 CARRIER PLACE
- **CITY:** FARMINGTON
- **STATE:** CT
- **ZIP:** 06032
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Otis Worldwide Corp
- **CENTRAL INDEX KEY:** 0001781335
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
- **IRS NUMBER:** 833789412
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** ONE CARRIER PLACE
- **CITY:** FARMINGTON
- **STATE:** CT
- **ZIP:** 06032
- **BUSINESS PHONE:** 8606743000

**MAIL ADDRESS:**
- **STREET 1:** ONE CARRIER PLACE
- **CITY:** FARMINGTON
- **STATE:** CT
- **ZIP:** 06032

## Exhibit 24.1

```

POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes
and appoints each of Nora LaFreniere, Toby Smith, Joshua Mullin,
Debra Guss and Caroline Coursant, signing individually, as the
undersigned's true and lawful attorney-in-fact to:

(1)	execute, for and on behalf of the undersigned, Forms 3, 4,
and 5 (and any replacement form or successor to such forms, as may
be established by the U.S. Securities and Exchange Commission from
time to time) in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended from time to time and the rules
thereunder;

(2)	execute, for and on behalf of the undersigned, any Form
144 (and any replacement form or successor to such form, as may
be established by the U.S. Securities and Exchange Commission
from time to time) required to be filed on behalf of the
undersigned in accordance with Rule 144 of the U.S. Securities
and Exchange Commission, as amended from time to time;

(3)	do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to
complete and execute any of the documents referred to in items
(1) and (2) above and timely file the same with the U.S.
Securities and Exchange Commission and any stock exchange or
similar authority; and

(4)	take any action of any type whatsoever in connection
with the foregoing (including but not limited to the execution
of any written representations required on behalf of the
undersigned to confirm compliance with Rule 144) which, in the
opinion of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the undersigned, it
being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act
and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not
assuming, nor is Otis Worldwide Corporation (the Company)
assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, Rule
144 of the U.S. Securities and Exchange Commission or any
other provision of the securities laws.

This Power of Attorney shall come into in full force and
effect on March 1, 2023 and shall remain in effect until
the undersigned is no longer required to file any of the
documents referred to above with respect to the
undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 26th day of February 2023.

Signed:  /s/ Sally Loh
	 Sally Loh

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Loh Sally<br><sub>(Last) (First) (Middle)</sub><br>1 CARRIER PLACE<br><sub>(Street)</sub><br>FARMINGTON, CT 06032<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Otis Worldwide Corp [ OTIS ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-03-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_President, Otis China_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 11579.12 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units (RSUs)<sup>(1)</sup> | <sup>(2)</sup> | <sup>(1)</sup> | Common Stock | 922 | 0<sup>(1)</sup> | D |  |
| Restricted Stock Units (RSUs)<sup>(1)</sup> | <sup>(3)</sup> | <sup>(1)</sup> | Common Stock | 566 | 0<sup>(1)</sup> | D |  |
| Restricted Stock Units (RSUs)<sup>(1)</sup> | <sup>(4)</sup> | <sup>(1)</sup> | Common Stock | 2187 | 0<sup>(1)</sup> | D |  |
| Restricted Stock Units (RSUs)<sup>(1)</sup> | <sup>(5)</sup> | <sup>(1)</sup> | Common Stock | 289 | 0<sup>(1)</sup> | D |  |
| Restricted Stock Units<sup>(1)</sup> | <sup>(6)</sup> | <sup>(1)</sup> | Common Stock | 8146 | 0<sup>(1)</sup> | D |  |
| Stock Appreciation Rights | <sup>(7)</sup> | 2033-02-06 | Common Stock | 3146 | $83.63 | D |  |
| Stock Appreciation Rights | <sup>(8)</sup> | 2032-02-02 | Common Stock | 3371 | $81.85 | D |  |
| Stock Appreciation Rights | <sup>(9)</sup> | 2031-02-04 | Common Stock | 3650 | $63.93 | D |  |
| Stock Appreciation Right | <sup>(10)</sup> | 2030-02-03 | Common Stock | 8314 | $80.97 | D |  |
| Stock Appreciation Right | <sup>(11)</sup> | 2029-02-04 | Common Stock | 9448 | $63.92 | D |  |
| Stock Appreciation Right | <sup>(12)</sup> | 2028-01-01 | Common Stock | 8125 | $67.83 | D |  |

---

### Footnotes:

(1) Restricted Stock Units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs.

(2) These RSUs are scheduled to vest in three substantially equal annual installments beginning on the first anniversary of the date of grant. The date of grant was February 7, 2023.

(3) These RSUs are scheduled to vest in two substantially equal annual installments on the second and third anniversaries of the date of grant. The date of  grant was February 3, 2022.

(4) These RSUs are scheduled to vest in two substantially equal annual installments on the second and third anniversaries of the date of grant. The  date of grant was June 1, 2021.

(5) These RSUs are scheduled to vest on the third anniversary of the date of grant. The date of grant was February 5, 2021.

(6) These RSUs are scheduled to vest in full on the third anniversary of the date of grant. The date of grant was June 1, 2020.

(7) These stock appreciation rights (SARs) were granted on February 7, 2023. They are scheduled to become exercisable in three substantially equal annual installments beginning on the first anniversary of the date of grant.

(8) These SARs were granted on February 3, 2022. 1,123 became exercisable on the first anniversary of the date of grant and the remainder are scheduled to become exercisable in two substantially equal annual installments on the second and third anniversaries of the date of grant.

(9) These SARs were granted on February 5, 2021. A total of 2,433 became exercisable on the first and second anniversaries of the date of grant and the remainder are scheduled to become exercisable on the third anniversary of the date of grant.

(10) These SARs were granted on February 4, 2020. They vested in full on the third anniversary of the date of grant.

(11) These SARs were granted on February 5, 2019. They vested in full on the third anniversary of the date of grant.

(12) These SARs were granted on January 2, 2018. They vested in full on the third anniversary of the date of grant.

**Signature:** Joshua Mullin, Attorney-in-Fact  
**Date:** 2023-03-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**